A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease

Lara Moussa (1) , Valérie Bézirard (2) , Christel Cartier (3) , Valérie Alquier-Bacquié (4) , Corinne Lencina (1) , Mathilde Lévêque (2) , Viorica Braniste (1) , Sandrine Ménard (2) , Vassilia Theodorou (2) , Eric Houdeau (3)

1 ToxAlim - ToxAlim
2 ToxAlim-NGN - Neuro-Gastroentérologie & Nutrition
3 ToxAlim-ENTeRisk - Endocrinologie & Toxicologie de la Barrière Intestinale
4 ToxAlim-TIM - Toxicologie Intégrative & Métabolisme

Pro-inflammatory cytokines like macrophage migration inhibitory factor (MIF), IL-1 beta and TNF-alpha predominate in inflammatory bowel diseases (IBD) and TNBS colitis. Increased levels of serine proteases activating protease-activated receptor 2 (PAR-2) are found in the lumen and colonic tissue of IBD patients. PAR-2 activity and pro-inflammatory cytokines impair epithelial barrier, facilitating the uptake of luminal aggressors that perpetuate inflammation and visceral pain. Soy extracts contain phytoestrogens (isoflavones) and serine protease inhibitors namely Bowman-Birk Inhibitors (BBI). Since estrogens exhibit anti-inflammatory and epithelial barrier enhancing properties, and that a BBI concentrate improves ulcerative colitis, we aimed to evaluate if a fermented soy germ extract (FSG) with standardized isoflavone profile and stable BBI content exert cumulative or synergistic protection based on protease inhibition and estrogen receptor (ER)-ligand activity in colitic rats. Female rats received orally for 15 d either vehicle or FSG with or without an ER antagonist ICI 182.780 before TNBS intracolonic instillation. Macroscopic and microscopic damages, myeloperoxidase activity, cytokine levels, intestinal paracellular permeability, visceral sensitivity, faecal proteolytic activity and PAR-2 expression were assessed 24 h, 3 d and 5 d post-TNBS. FSG treatment improved the severity of colitis, by decreasing the TNBS-induced rise in gut permeability, visceral sensitivity, faecal proteolytic activity and PAR-2 expression at all post-TNBS points. All FSG effects were reversed by the ICI 182.780 except the decrease in faecal proteolytic activity and PAR-2 expression. In conclusion, the anti-inflammatory properties of FSG treatment result from two distinct but synergic pathways i.e an ER-ligand and a PAR-2 mediated pathway, providing rationale for potential use as adjuvant therapy in IBD.

Domaines: Sciences du Vivant [q-bio]

Lara Moussa, Valérie Bézirard, Christel Cartier, Valérie Alquier-Bacquié, Corinne Lencina, et al.. A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease. PLoS ONE, 2012, 7 (11), pp.e49547. ⟨10.1371/journal.pone.0049547⟩. ⟨hal-02643865⟩